KKK

Klotho Neurosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪8.29 M‬USD
−0.0025USD
‪1.35 M‬USD
0.00USD
‪16.49 M‬
Beta (1Y)
1.35
Employees (FY)
2
Change (1Y)
0
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪673.06 K‬USD

About Klotho Neurosciences, Inc.


CEO
Joseph Sinkule
Headquarters
Omaha
Founded
2004
FIGI
BBG015Z249H2
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It operates through the following segments: Generic Drugs, Gene Therapy, and Pharmaceutical Programs. The Generic Drugs segment consists of a portfolio of drugs and biosimilar biologics selling hard-to-source, difficult to find generic drugs and off-patent biologic therapies, and proprietary and patented technology platforms that include a library of melanocortin receptor-binding molecules. The Gene Therapy segment focuses on the gene therapy approach to introduce a therapeutic protein called “Klotho” inside the body to treat neurodegenerative diseases and other diseases of aging. The Pharmaceutical Programs segment includes treatments using small drug molecules that bind to the melanocortin receptors on human cells and affect skin pigmentation and other initiatives. The company was founded on August 2, 2004 and is headquartered in Omaha, NE.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KLTO is 0.3500 USD — it has decreased by −2.52% in the past 24 hours. Watch Klotho Neurosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Klotho Neurosciences, Inc. stocks are traded under the ticker KLTO.
KLTO stock has fallen by −23.51% compared to the previous week, the month change is a −24.86% fall, over the last year Klotho Neurosciences, Inc. has showed a −96.73% decrease.
KLTO reached its all-time high on Apr 19, 2024 with the price of 13.1000 USD, and its all-time low was 0.3900 USD and was reached on Nov 1, 2024. View more price dynamics on KLTO chart.
See other stocks reaching their highest and lowest prices.
KLTO stock is 44.41% volatile and has beta coefficient of 1.35. Track Klotho Neurosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Klotho Neurosciences, Inc. there?
Today Klotho Neurosciences, Inc. has the market capitalization of ‪8.29 M‬, it has decreased by −6.61% over the last week.
Yes, you can track Klotho Neurosciences, Inc. financials in yearly and quarterly reports right on TradingView.
KLTO net income for the last quarter is ‪−451.64 K‬ USD, while the quarter before that showed ‪−123.22 K‬ USD of net income which accounts for −266.52% change. Track more Klotho Neurosciences, Inc. financial stats to get the full picture.
No, KLTO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 2.00 employees. See our rating of the largest employees — is Klotho Neurosciences, Inc. on this list?
Like other stocks, KLTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Klotho Neurosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Klotho Neurosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Klotho Neurosciences, Inc. stock shows the sell signal. See more of Klotho Neurosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.